Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hereditary Breast and Ovarian Cancer clinical trials
2 of 6 indexed Hereditary Breast and Ovarian Cancer trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Hereditary Breast and Ovarian Cancer: 6 US clinical trials tracked, 2 recruiting.
Hereditary Breast and Ovarian Cancer is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Georgetown University, running 3 of these trials.
Enrollment posture brief
Registry condition hereditary-breast-and-ovarian-cancer
OPEN 2 | RECR 33% | LATE 0 | EARLY 0 | RANK #2866 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Hereditary Breast and Ovarian Cancer lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hereditary Breast and Ovarian Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hereditary Breast and Ovarian Cancer is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hereditary Breast and Ovarian Cancer research.
Georgetown University accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.
-
Typical Hereditary Breast and Ovarian Cancer enrolment sits around 332 participants.
Median target enrolment is 332 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
Hereditary Breast and Ovarian Cancer splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry
University of Kansas Medical Center
NCT02302742
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Georgetown University
NCT05130606
Scalable Communication Modalities for Returning Genetic Research Results
Boston University
NCT04407611
Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment
Georgetown University
NCT03511690
Enhancing At-risk Latina Women's Use of Genetic Counseling for Hereditary Breast and Ovarian Cancer
Georgetown University
NCT03075540
Genetic Risk: Whether, When, and How to Tell Adolescents
Johns Hopkins University
NCT03421327
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Hereditary Breast and Ovarian Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hereditary Breast and Ovarian Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hereditary Breast and Ovarian Cancer page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Hereditary Breast and Ovarian Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Georgetown University sponsors the most Hereditary Breast and Ovarian Cancer trials on record, review their full trial history before evaluating a specific study. See Georgetown University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hereditary Breast and Ovarian Cancer condition card totals 6 registered trials; most-linked intervention Genetic Counseling and Testing YouTube Video; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.